ATE3768T1 - Furyl-nonatetraen-derivate und deren pharmazeutisch zulaessigen salze, verfahren zu ihrer herstellung, in diesen verfahren verwendete ausgangsstoffe, und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Furyl-nonatetraen-derivate und deren pharmazeutisch zulaessigen salze, verfahren zu ihrer herstellung, in diesen verfahren verwendete ausgangsstoffe, und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE3768T1
ATE3768T1 AT79102681T AT79102681T ATE3768T1 AT E3768 T1 ATE3768 T1 AT E3768T1 AT 79102681 T AT79102681 T AT 79102681T AT 79102681 T AT79102681 T AT 79102681T AT E3768 T1 ATE3768 T1 AT E3768T1
Authority
AT
Austria
Prior art keywords
processes
formula
furyl
derivatives
nonatetraen
Prior art date
Application number
AT79102681T
Other languages
English (en)
Inventor
Michael Rosenberger
Original Assignee
F. Hoffmann-La Roche & Co. Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche & Co. Aktiengesellschaft filed Critical F. Hoffmann-La Roche & Co. Aktiengesellschaft
Application granted granted Critical
Publication of ATE3768T1 publication Critical patent/ATE3768T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyethers (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT79102681T 1978-08-24 1979-07-27 Furyl-nonatetraen-derivate und deren pharmazeutisch zulaessigen salze, verfahren zu ihrer herstellung, in diesen verfahren verwendete ausgangsstoffe, und sie enthaltende pharmazeutische zusammensetzungen. ATE3768T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/936,467 US4216312A (en) 1978-08-24 1978-08-24 Furyl substituted polyenes
EP79102681A EP0008665B1 (de) 1978-08-24 1979-07-27 Furyl-nonatetraen-Derivate und deren pharmazeutisch zulässigen Salze, Verfahren zu ihrer Herstellung, in diesen Verfahren verwendete Ausgangsstoffe, und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE3768T1 true ATE3768T1 (de) 1983-06-15

Family

ID=25468687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79102681T ATE3768T1 (de) 1978-08-24 1979-07-27 Furyl-nonatetraen-derivate und deren pharmazeutisch zulaessigen salze, verfahren zu ihrer herstellung, in diesen verfahren verwendete ausgangsstoffe, und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (13)

Country Link
US (1) US4216312A (de)
EP (1) EP0008665B1 (de)
JP (1) JPS5531089A (de)
AT (1) ATE3768T1 (de)
AU (1) AU526146B2 (de)
CA (1) CA1163643A (de)
DE (1) DE2965657D1 (de)
DK (1) DK158946C (de)
IE (1) IE48808B1 (de)
IL (1) IL58065A (de)
NZ (1) NZ191346A (de)
PH (1) PH16278A (de)
ZA (1) ZA794341B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395575A (en) * 1975-11-14 1983-07-26 Hoffmann-La Roche, Inc. 5(Halophenyl)-2-fluoro-pentadienals
US4299995A (en) * 1979-05-10 1981-11-10 Hoffmann-La Roche Inc. Fluorinated polyenes
US4335248A (en) * 1975-11-14 1982-06-15 Hoffmann-La Roche Inc. Fluorinated polyenes
US5968989A (en) * 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7056954B2 (en) * 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US6992108B1 (en) * 1991-12-18 2006-01-31 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
JP2003055367A (ja) * 2001-08-15 2003-02-26 Kuraray Co Ltd 3−ホルミルフラン類の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH582668A5 (de) * 1973-08-10 1976-12-15 Hoffmann La Roche
US3948758A (en) * 1974-06-17 1976-04-06 Mobil Oil Corporation Production of alkyl aromatic hydrocarbons
US4086420A (en) * 1975-01-23 1978-04-25 Sagami Chemical Research Center Thioprene or furan derivatives and process for preparation thereof
AT351515B (de) 1976-12-20 1979-07-25 Hoffmann La Roche Verfahren zur herstellung von neuen polyenver- bindungen
JPS5257107A (en) * 1975-10-30 1977-05-11 Hoffmann La Roche Polyene compound and method of producing same
US4061656A (en) * 1975-11-14 1977-12-06 Hoffmann-La Roche Inc. Polyene compounds
JPS5313029A (en) * 1976-07-20 1978-02-06 Mitsubishi Electric Corp Igniter for internal combustion engine
CA1111441A (en) * 1976-12-20 1981-10-27 Werner Bollag Polyene compounds
LU77254A1 (de) * 1977-05-04 1979-01-18

Also Published As

Publication number Publication date
EP0008665A1 (de) 1980-03-19
AU526146B2 (en) 1982-12-16
AU5026679A (en) 1980-02-28
CA1163643A (en) 1984-03-13
IL58065A0 (en) 1979-12-30
PH16278A (en) 1983-08-26
DK158946B (da) 1990-08-06
DE2965657D1 (en) 1983-07-21
EP0008665B1 (de) 1983-06-15
IE791613L (en) 1980-02-24
ZA794341B (en) 1980-08-27
JPS636548B2 (de) 1988-02-10
JPS5531089A (en) 1980-03-05
IE48808B1 (en) 1985-05-29
US4216312A (en) 1980-08-05
DK352879A (da) 1980-03-31
NZ191346A (en) 1984-03-30
DK158946C (da) 1991-01-21
IL58065A (en) 1983-09-30

Similar Documents

Publication Publication Date Title
NL940004I1 (nl) Piperazinecarboxamide- en -carbothioamidederivatenwerkwijze ter bereiding daarvan alsmede farmaceut isch preparaat dat een dergelijk derivaat omvat
ATE4903T1 (de) 1-, 6- und 2-substituierte 1-carba-2-penem-3carbons[ure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
ATE163923T1 (de) 25-carbonsäure-derivate in der vitamin d-reihe, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
DE69606840D1 (de) Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung
DE59005254D1 (de) 24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel.
IE44942L (en) Piperazine and piperidine derivatives
NO940523L (no) Nye pyrazin-derivater
KR950008468A (ko) 방향족 카복실산 유도체
ATE22291T1 (de) 1.1-disubstituierte 6-(1-hydroxyethyl)-2(aminoethylthio)-1-carbadethiapen-2emcarbons|uren, verfahren zu ihrer herstellung, antibiotisch wirksame pharmazeutische zusammensetzungen, die diese verbindungen enthalten, zwischenprodukte zu ihrer herstellung und verfahren zur herstellung der in diesem verfahren verwendbaren zwischenprodukte.
ATE3768T1 (de) Furyl-nonatetraen-derivate und deren pharmazeutisch zulaessigen salze, verfahren zu ihrer herstellung, in diesen verfahren verwendete ausgangsstoffe, und sie enthaltende pharmazeutische zusammensetzungen.
EP0009777B1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
ES8307224A1 (es) Un metodo para preparar derivados de pirazolina.
ATE144507T1 (de) Dithian substituierte retinoide, ihre verwendung, verfahren zu ihrer herstellung, diese enthaltende kosmetische und pharmazeutische zusammensetzungen und ihre therapeutische verwendung
SE7906681L (sv) Ftalazonderivat
RU98113854A (ru) Эфирные производные транс-аповинкаминовой кислоты в качестве лекарственных средств
ATE55120T1 (de) 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die bekaempfung von herz- und gefaesskrankheiten.
ATE3031T1 (de) Anilinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
KR900006287A (ko) 2-[4-(2-피페리디노-에톡시)-벤조일]-벤조산의 측쇄 알킬 에스테르, 이의 제조 방법 및 진경제로서의 이의 용도
DK214884D0 (da) Chlorphenoxyacetatderivat
RU93058275A (ru) Производные тиофен-2-карбоновой кислоты, способ их получения, фармацевтическая композиция и способ ее получения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee